Rudat V - Search Results

1

Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary.

Douglas S, Huttenlocher S, Bajrovic A, Rudat V, Schild SE, Rades D. Douglas S, et al. Among authors: rudat v. BMC Cancer. 2012 Jun 21;12:261. doi: 10.1186/1471-2407-12-261. BMC Cancer. 2012. PMID: 22720880 Free PMC article.

2

Repeatability and prognostic impact of the pretreatment pO(2) histography in patients with advanced head and neck cancer.

Rudat V, Vanselow B, Wollensack P, Bettscheider C, Osman-Ahmet S, Eble MJ, Dietz A. Rudat V, et al. Radiother Oncol. 2000 Oct;57(1):31-7. doi: 10.1016/s0167-8140(00)00200-0. Radiother Oncol. 2000. PMID: 11033186 Clinical Trial.

3

Is there a dose-effect relationship for the treatment of symptomatic vertebral hemangioma?

Rades D, Bajrovic A, Alberti W, Rudat V. Rades D, et al. Among authors: rudat v. Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):178-81. doi: 10.1016/s0360-3016(02)03734-3. Int J Radiat Oncol Biol Phys. 2003. PMID: 12504051

4

Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients?

Bajrovic A, Rades D, Fehlauer F, Tribius S, Hoeller U, Rudat V, Jung H, Alberti W. Bajrovic A, et al. Among authors: rudat v. Radiother Oncol. 2004 Jun;71(3):297-301. doi: 10.1016/j.radonc.2004.03.005. Radiother Oncol. 2004. PMID: 15172145

5

Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy: the importance of pretreatment hemoglobin levels.

Rades D, Schild SE, Bahrehmand R, Zschenker O, Alberti WA, Rudat VR. Rades D, et al. Cancer. 2005 Apr 15;103(8):1740-6. doi: 10.1002/cncr.20952. Cancer. 2005. PMID: 15742330 Free article.

6

Epoetin-alpha during radiotherapy for stage III esophageal carcinoma.

Rades D, Schild SE, Yekebas EF, Job H, Schwarz R, Rudat V. Rades D, et al. Among authors: rudat v. Cancer. 2005 Jun 1;103(11):2274-9. doi: 10.1002/cncr.21042. Cancer. 2005. PMID: 15852356 Free article.

7

Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.

Rades D, Stalpers LJ, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC, Poortmans P, Schild SE. Rades D, et al. Among authors: rudat v. J Clin Oncol. 2005 May 20;23(15):3366-75. doi: 10.1200/JCO.2005.04.754. J Clin Oncol. 2005. PMID: 15908648

8

Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.

Rades D, Veninga T, Stalpers LJ, Schulte R, Hoskin PJ, Poortmans P, Schild SE, Rudat V. Rades D, et al. Among authors: rudat v. Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):182-8. doi: 10.1016/j.ijrobp.2005.06.036. Epub 2005 Sep 28. Int J Radiat Oncol Biol Phys. 2006. PMID: 16198069

9

Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer.

Rades D, Stalpers LJ, Veninga T, Rudat V, Schulte R, Hoskin PJ. Rades D, et al. Among authors: rudat v. J Urol. 2006 Feb;175(2):552-6. doi: 10.1016/S0022-5347(05)00241-7. J Urol. 2006. PMID: 16406994

10

Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.

Rades D, Fehlauer F, Schulte R, Veninga T, Stalpers LJ, Basic H, Bajrovic A, Hoskin PJ, Tribius S, Wildfang I, Rudat V, Engenhart-Cabilic R, Karstens JH, Alberti W, Dunst J, Schild SE. Rades D, et al. Among authors: rudat v. J Clin Oncol. 2006 Jul 20;24(21):3388-93. doi: 10.1200/JCO.2005.05.0542. J Clin Oncol. 2006. PMID: 16849752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

117 results

Search Page